Drug Profile
Ethinylestradiol/desogestrel - Teva
Alternative Names: DR-102; DR-1021; LeCetteLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Teva Pharmaceutical Industries
- Class Alkylated estrogenic steroids; Hormonal contraceptives; Norpregnatrienes; Norpregnenes; Oral contraceptives
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pregnancy
Most Recent Events
- 02 Feb 2014 Teva Pharmaceutical Industries has patent protection for ethinylestradiol/desogestrel in USA
- 30 Sep 2013 Preregistration for Contraception/Pregnancy (Prevention) in USA (PO)
- 08 May 2013 Efficacy and adverse events data from a phase I trial in Contraception/Pregnancy (Prevention) released by Teva Pharmaceutical Industries